Mdm2 Expression is Induced by Wild Type P53 Activity

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1993 Feb 1

PMID 8440237

Citations 445

Authors

Y Barak

T Juven

R Haffner

M Oren

Affiliations

Soon will be listed here.

Abstract

We have recently characterized a 95 kDa protein, p95, which exhibits enhanced binding to temperature-sensitive p53 (ts-p53) when cells are shifted down to 32.5 degrees C, a temperature at which ts-p53 possesses wild-type (wt)-like activities. In the present study we show that p95 is a product of the mdm2 putative proto-oncogene. The enhanced complex formation of mdm2 with ts-p53 in cells maintained at 32.5 degrees C is due to an elevation in total mdm2 protein levels following the temperature shift. We further demonstrate that the induction of mdm2 expression by t p53 activity is at the mRNA level. The induction occurs with very rapid kinetics and does not require de novo protein synthesis, suggesting a direct involvement of p53 in the process. Based on these data and on recent findings implicating p53 as a transcription factor, we suggest that the mdm2 gene is a target for activation by wt p53. In view of the ability of mdm2 to act as a specific antagonist of p53 activity, this induction process may serve to tightly autoregulate p53 activity in living cells.

Citing Articles

The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy.

Hatletvedt N, Engebrethsen C, Geisler J, Geisler S, Aas T, Lonning P BMC Cancer. 2025; 25(1):308.

PMID: 39979836 PMC: 11843751. DOI: 10.1186/s12885-025-13675-2.

Divergent PTEN-p53 interaction upon DNA damage in a human thyroid organoid model with germline PTEN mutations.

Venegas J, Onur O, Kang S, Hitomi M, Eng C Endocr Relat Cancer. 2025; 32(4).

PMID: 39970536 PMC: 11906015. DOI: 10.1530/ERC-24-0216.

Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53.

Taritsa I, Fossel E Front Pharmacol. 2025; 16:1529483.

PMID: 39944631 PMC: 11813898. DOI: 10.3389/fphar.2025.1529483.

MDM2 functions as a timer reporting the length of mitosis.

Fulcher L, Sobajima T, Batley C, Gibbs-Seymour I, Barr F Nat Cell Biol. 2025; 27(2):262-272.

PMID: 39789219 PMC: 11821534. DOI: 10.1038/s41556-024-01592-8.

Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells.

Zhang Y, Liu Y, Xing X, Liu H, Guan W Viruses. 2024; 16(11).

PMID: 39599840 PMC: 11598893. DOI: 10.3390/v16111725.

References

Levine A, Momand J, Finlay C . The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-6. DOI: 10.1038/351453a0. View

El-Deiry W, Kern S, Pietenpol J, Kinzler K, Vogelstein B . Definition of a consensus binding site for p53. Nat Genet. 1992; 1(1):45-9. DOI: 10.1038/ng0492-45. View

Weintraub H, Hauschka S, Tapscott S . The MCK enhancer contains a p53 responsive element. Proc Natl Acad Sci U S A. 1991; 88(11):4570-1. PMC: 51706. DOI: 10.1073/pnas.88.11.4570. View

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M . Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 1991; 352(6333):345-7. DOI: 10.1038/352345a0. View

Santhanam U, Ray A, Sehgal P . Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A. 1991; 88(17):7605-9. PMC: 52350. DOI: 10.1073/pnas.88.17.7605. View

Foord O, Bhattacharya P, Reich Z, Rotter V . A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res. 1991; 19(19):5191-8. PMC: 328875. DOI: 10.1093/nar/19.19.5191. View

Shaulsky G, Goldfinger N, Peled A, Rotter V . Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci U S A. 1991; 88(20):8982-6. PMC: 52635. DOI: 10.1073/pnas.88.20.8982. View

Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Craig R . Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51(23 Pt 1):6304-11. View

10.

Raycroft L, Schmidt J, Yoas K, Hao M, Lozano G . Analysis of p53 mutants for transcriptional activity. Mol Cell Biol. 1991; 11(12):6067-74. PMC: 361778. DOI: 10.1128/mcb.11.12.6067-6074.1991. View

11.

Ginsberg D, Mechta F, Yaniv M, Oren M . Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci U S A. 1991; 88(22):9979-83. PMC: 52850. DOI: 10.1073/pnas.88.22.9979. View

12.

Chin K, Ueda K, Pastan I, Gottesman M . Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science. 1992; 255(5043):459-62. DOI: 10.1126/science.1346476. View

13.

Unger T, Nau M, Segal S, Minna J . p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J. 1992; 11(4):1383-90. PMC: 556587. DOI: 10.1002/j.1460-2075.1992.tb05183.x. View

14.

Yew P, Berk A . Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature. 1992; 357(6373):82-5. DOI: 10.1038/357082a0. View

15.

Shaw P, BOVEY R, Tardy S, Sahli R, Sordat B, Costa J . Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A. 1992; 89(10):4495-9. PMC: 49109. DOI: 10.1073/pnas.89.10.4495. View

16.

Funk W, Pak D, Karas R, Wright W, Shay J . A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol. 1992; 12(6):2866-71. PMC: 364481. DOI: 10.1128/mcb.12.6.2866-2871.1992. View

17.

Kern S, Pietenpol J, Thiagalingam S, Seymour A, Kinzler K, Vogelstein B . Oncogenic forms of p53 inhibit p53-regulated gene expression. Science. 1992; 256(5058):827-30. DOI: 10.1126/science.1589764. View

18.

Barak Y, Oren M . Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 1992; 11(6):2115-21. PMC: 556678. DOI: 10.1002/j.1460-2075.1992.tb05270.x. View

19.

Lane D . Cancer. p53, guardian of the genome. Nature. 1992; 358(6381):15-6. DOI: 10.1038/358015a0. View

20.

Oliner J, Kinzler K, Meltzer P, GEORGE D, Vogelstein B . Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 1992; 358(6381):80-3. DOI: 10.1038/358080a0. View